Invivyd, Inc.

US$0.56As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:IVVDHealthcare
Country USA
PE (Fwd) •••
TSR 5Y CAGR (54.59%)
Div yield —
ROE (95.89%)
Biotechnology
Beta (5Y) 1.29
PE TTM —
TSR TTM (68.01%)
Mkt cap US$165.9M
ROIC (59.80%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.547
(2.79%)
(29.94%)
Hold 8|2|12|2|12
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.01
0.01
0.01
0.01
11.11%
4.76%
8.06%
13.82%
Revenue$M
13.05
12.67
13.22
12.97
2.99%
(1.21%)
5.45%
0.56%
Peers (US$165.9M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
1.150
1.258
1.216
EBIT/Intx
0.770
0.272
0.319
Own earn%
12.67
291.21
231.40
Sh yield%
31.92
19.18
18.67
Owners
Insiders/Inst%
11.71
84.04
Short interest%
0.74
SBC / revenue%
4.66
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
16
Op margin range%
30–35
$1 testx
—
Incr. ROIC%
1